Xeris Pharmaceuticals | XERS - Ordinary Share Capital

Stock Price
5.50
Daily Change
0.04 0.64%
Monthly
-20.48%
Yearly
9.24%
Q1 Forecast
5.30

Xeris Pharmaceuticals reported $165.53M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Celltrion KRW 218.78M 1.5M Sep/2025
Cspc Pharmaceutical CNY 11.52B 486M Jun/2025
Deva Holding AS TRY 200.02M 0 Sep/2023
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Divis Laboratories Ltd INR 265.47M 264.53M Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Kangmei Pharma CNY 13.86B 0 Jun/2025
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 112.66M 2.35M Dec/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Organigram Holdings CAD 134.46M 438.86K Sep/2025
Ovoca Bio EUR 11.06M 0 Jun/2022
Pacira USD 41.12M 1.85M Dec/2025
Perrigo USD 137.6M 0 Dec/2025
Pharma Mar EUR 17.36M 214.99K Dec/2025
Qiagen NV USD 216.56M 284.67K Dec/2025
Sartorius EUR 69.04M 0 Sep/2025
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Tilray USD 1.06B 86.93M Mar/2025
Zz Pientze Pharmaceu CNY 603.32M 0 Sep/2025